
Sign up to save your podcasts
Or


Jef Akst, managing editor at BioSpace, talks about the major CGT issues she's been covering at #ASGCT2024 including regulatory considerations and AAV manufacturing. She also tells host Lynnea Olivarez what she hopes to be reporting on next year at the ASGCT Annual Meeting in New Orleans!
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information.
By American Society of Gene & Cell Therapy4.9
1616 ratings
Jef Akst, managing editor at BioSpace, talks about the major CGT issues she's been covering at #ASGCT2024 including regulatory considerations and AAV manufacturing. She also tells host Lynnea Olivarez what she hopes to be reporting on next year at the ASGCT Annual Meeting in New Orleans!
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information.

43,816 Listeners

30,641 Listeners

43,659 Listeners

26,052 Listeners

752 Listeners

151 Listeners

819 Listeners

6,457 Listeners

113,434 Listeners

56,991 Listeners

338 Listeners

16,512 Listeners

6,461 Listeners

16,530 Listeners

38 Listeners